BioSpace News Archive

FDA

FDA Approves J&J’s Darzalex Faspro for Rare Light Chain Amyloidosis

The U.S. Food and Drug Administration approved Janssen Pharmaceuticals’ Darzalex Faspro for adults with newly diagnosed light chain amyloidosis.

January 18, 2021
·
3 min read
·
Mark Terry
Policy

Pfizer CEO Backs Biden’s Plan for 100 Million Doses in 100 Days

Will there be enough doses of the two authorized mRNA COVID-19 vaccines to meet the lofty goal of 100 million inoculations within 100 days of the start of Joe Biden’s presidential administration?

January 18, 2021
·
3 min read
·
Alex Keown
BioForest

Sana Bio’s $150 Million IPO Expected to Provide Market Valuation of $10 Billion

Despite its lofty valuation, the company does not yet have any drugs in the clinic, although it expects to submit Investigational New Drug applications in 2022 and 2023.

January 18, 2021
·
3 min read
·
Mark Terry
FDA

Enhertu Snags FDA Approval for HER2-Positive Gastric Cancer Patients

Daiichi Sankyo’s and AstraZeneca’s Enhertu (fam-trastuzumab deruxtecan-nxki) has become the first HER2-directed medication approved to treat gastric cancer in the U.S. in 10 years.

January 18, 2021
·
2 min read
·
Alex Keown
LexaGene Launches EUA Tests for Microfluidic PCR Device in Point-of-Care Facilities

LexaGene has begun a series of studies aimed to bring its MiQLab from research-only use to point-of-care use to detect the SARS-CoV-2 virus.

January 18, 2021
·
4 min read
·
Gail Dutton
Drug Development

Biohaven’s Prodrug Troriluzole Strikes Out Again, This Time Against Alzheimer’s

Being studied for GAD, OCD, AD and spinocerebellar ataxia, Biohaven’s troriluzole has now struck out in 3 late-stage studies.

January 18, 2021
·
2 min read
·
Kate Goodwin
n-Lorem Foundation Preps First Doses to Treat Ultra-Rare Disease Patients for Free

n-Lorem Foundation has taken on a challenge that many nations consider too great: treating patients with ultra-rare diseases (which affect 30 or fewer people) for free, for life.

January 18, 2021
·
4 min read
·
Gail Dutton
Zika Virus Vaccine Market: Preventive Segment to Witness Significant Growth

Zika virus disease is caused by a virus transmitted primarily by Aedes mosquitoes, which bite during the day. It is also transmitted through sexual contact with an infected person or through an infected pregnant woman to the fetus.

January 18, 2021
·
5 min read
Increasing Incidences of Chronic Diabetes to Help Uptake of Advance Wound Care Market, Finds Fact.MR

According to the recently published market research report by Fact.MR, the global advance wound care market is expected to develop at a decent CAGR of ~4% over the course of the given forecast period ranging from 2020 to 2030.

January 18, 2021
·
3 min read
Paradigm Shift to One-time Use Product to Help Improve Sales of Hospital Supplies Market, Finds Fact.MR

Companies operating in the global hospital supplies market are rapidly shifting from manufacturing non-disposable to disposable one-time-use products.

January 18, 2021
·
3 min read